Vanda is a global biopharmaceutical company.

Vanda is a global biopharmaceutical company.

Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises.

Corporate Officers

Working together for a common goal.

BOARD OF DIRECTORS

Knowledge. Experience. Commitment.

BOARD OF DIRECTORS

Corporate Governance

Audit Committee

Richard W. Dugan (Financial Expert)
Chair, Member

Michael F. Cola
Member

Phaedra Chrousos
Member

Compensation Committee

H. Thomas Watkins
Chair, Member

Richard W. Dugan
Member

Anne Sempowski Ward
Member

Nominating / Corporate Governance Committee

Michael F. Cola
Chair, Member

H. Thomas Watkins
Member

Phaedra Chrousos
Member